TrialHaematologica2017

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

Ute Hegenbart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.